Fuller & Thaler Asset Management
PCRX icon

Fuller & Thaler Asset Management’s Pacira BioSciences PCRX Stock Holding History

Fuller & Thaler Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-68,445
Closed -$6.08M – 719
2015
Q1 		$6.08M Sell
68,445
-105
-0.2% -$10.7K 0.19% 110
2014
Q4 		$6.08M Sell
68,550
-100
-0.1% -$9.46K 0.22% 104
2014
Q3 		$6.65M Sell
68,650
-100
-0.1% -$9.73K 0.29% 96
2014
Q2 		$6.32M Buy
+68,750
New +$5.24M 0.27% 110

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management's PCRX Position: Q2 2015 in Review

Fuller & Thaler Asset Management sold out of Pacira BioSciences (PCRX) in Q2 2015, closing a stake of 68,445 shares — an estimated $6.08M sold.

Fuller & Thaler Asset Management first reported a position in PCRX in Q2 2014 and held it in 4 quarters. The position peaked at $6.65M in Q3 2014. 187 funds tracked by Wall St. Rank hold PCRX as of Q2 2015.

  • Fuller & Thaler Asset Management reported no remaining Pacira BioSciences position as of Q2 2015 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 68,445 Pacira BioSciences shares in Q2 2015, an estimated $6.08M.
  • Fuller & Thaler Asset Management first reported a position in Pacira BioSciences in Q2 2014 and held it in 4 quarters.
  • Fuller & Thaler Asset Management's Pacira BioSciences position peaked at $6.65M in Q3 2014.
  • 187 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2015.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2015, filed 17 Aug 2015.